mortality/aging
• in vesicular somatitis virus (VSV)-infected mice
|
immune system
• splenocytes proliferate against the antigen and a mitogen more vigorously than those from wild-type
|
• in trinitrophenyl-conjugated ovalbumin-treated mice
|
• in trinitrophenyl-conjugated ovalbumin-treated mice
|
• mice exhibit a slightly reduced CTL response against lymphocytic choriomeningitis virus (LCMV) infection with enhanced viral replication compared with similarly treated wild-type mice
|
• stimulation of splenocytes with an antigen or a mitogen induces a higher production of IFN-gamma than in wild-type
|
• stimulation of splenocytes with an antigen induces a higher production of IL-4, IL-6, IL-13 and IFN-gamma than in wild-type
• stimulation of splenocytes with a mitogen induces a higher production of IL-13
|
• following induction of experimental myasthenia gravis, mice exhibit less severe disease compared with wild-type mice
|
• exhibit increased incidence and severity of induced experimental autoimmune uveoretinitis compared to wild-type (59.3% vs. 40% of wild-type)
• upon uveoretinitis induction, see a significant infiltration of eosinophils into the eyes compared to wild-type
|
• following infection with Listeria monocytogenes, mice exhibit 100-fold increase in bacterial titers in the liver and 10-fold in the spleen compared to in similarly treated wild-type mice
|
• mice infected with vesicular somatitis virus (VSV) exhibit a 100- to 1000-fold increase in viral titers and increased lethality compared with similarly treated wild-type mice
• mice exhibit a slightly reduced CTL response against lymphocytic choriomeningitis virus (LCMV) infection with enhanced viral replication compared with similarly treated wild-type mice
|
• in vesicular somatitis virus (VSV)-infected mice
|
neoplasm
• tumor growth in tumor-bearing mice treated with Th-17-polarized cells from Tg(Tcra,Tcrb)9Rest cells is minimally delayed, and develop progressive disease
|
liver/biliary system
N |
• mice show no liver injury on treatment with HBsAg-specific Th1 cells and HBsAg
|
hematopoietic system
• splenocytes proliferate against the antigen and a mitogen more vigorously than those from wild-type
|
• in trinitrophenyl-conjugated ovalbumin-treated mice
|
• in trinitrophenyl-conjugated ovalbumin-treated mice
|
• mice exhibit a slightly reduced CTL response against lymphocytic choriomeningitis virus (LCMV) infection with enhanced viral replication compared with similarly treated wild-type mice
|
cellular
• splenocytes proliferate against the antigen and a mitogen more vigorously than those from wild-type
|